An expert on premium research reports, Market Research Future has added a report titled “Global Radiotherapy Market 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.
The Radiotherapy Market will grow very rapidly at a rate of 7% CAGR during the forecasted period 2017-2023. The market is expected to reach USD 7 million from 4.5 million in 2016 during the forecasted period.
Radiotherapy is generally used as a treatment for cancer. Around four out of every ten people are treated for cancer undergo radiotherapy. Normally together with other types of treatment including chemotherapy and surgery. Radiotherapy usually uses high power X-rays to destroy unwanted cells, such as cancer cells. The focus of radiotherapy is to destroy the unwanted cells and avoid damaging healthy cells as much as possible. The damages cell stops repairing itself when the cell is damaged through DNA and are broken down by the natural process of body. The radiotherapy treatment are less painful than the chemotherapy and surgeries. The radiotherapy also have some side effects along with it. The side-effects of radiation therapy are nausea, hair loss, skin problems, fatigue, appetite loss, diarrhea, fertility issues could potentially hamper radiotherapy devices market growth.
Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/1526
Key players of Global Radiotherapy market:
GE Healthcare(UK), Siemens (Germany), Varian(India), Cardinal Health(US), Nordion(CA), Isoray(US), View ray (US), Fuji Holdings(Japan), Philips Healthcare (US), Shimadzu Corporation (Japan), Hologic (US).
Jan, 2018 Varian Medical Systems signed an agreement to acquire Sirtex Medical Limited. This acquisition expands Varian’s addressable market into interventional oncology to emerge as a global leader in radio embolization.
October, 2017 Varian has launched its radiotherapy device ProBeam Compact single-room proton therapy system.
July, 2017 View Ray has recently announced the launch of MRI-guided radiation therapy solution, MRIdian Linac.
The segmentation for the Radiotherapy Market is done on the basis of the treatment type and by application. On the basis of treatment type includes X-Ray, Gamma ray, External Beam radiotherapy, proton therapy, internal radiation therapy. The external beam radiotherapy segment is further sub-segmented into the treatment types which are 3D conformal radiation therapy, intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), Tomotherapy, Stereotactic radio surgery, and stereotactic body radiation therapy. On the basis of the application the segment are prostate cancer, breast cancer and lung cancer, ovarian cancer and thyroid.
The Radiotherapy Market is segmented into four main geographic regions Americas, Europe, Asia-Pacific, and Middle East and Africa. America holds the larger market in the radiotherapy the market increasing due to the increasing advancement in the technology. Europe is another dominating region for the use of the radiotherapy. Asia-pacific region is growing at a rapid pace because of the increasing number of patients in the region. The number is increasing due to the more consumptions of tobacco is seen in this region. Middle East and Africa is slow growing segment because of the lack of awareness of the chronic diseases and the treatment facilities are also limited in this region.
TABLE OF CONTENTS
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
Browse Full Reports @ https://www.marketresearchfuture.com/reports/radiotherapy-market-1526
3 Market Dynamics
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312